Literature DB >> 10199529

Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage.

A Gruber1, A Reinprecht, U M Illievich, R Fitzgerald, W Dietrich, T Czech, B Richling.   

Abstract

OBJECTIVE: To analyze the influence of extracerebral organ system dysfunction after aneurysmal subarachnoid hemorrhage (SAH) on mortality and neurologic outcome.
DESIGN: Observational study with retrospective data extraction.
SETTING: Neurosurgical intensive care unit (NICU) at a primary level university hospital, supervised and staffed by both members of the Clinic of Neurosurgery and the Clinic of Anesthesiology and General Intensive Care. PATIENTS: Two hundred forty-two patients treated for intracranial aneurysm rupture within 7 days of the most recent SAH.
INTERVENTIONS: Routine neurosurgical interventions for obliteration of the ruptured aneurysm (microsurgery, Guglielmi Detachable Coils embolization) and for treatment of posthemorrhagic hydrocephalus (ventriculostomy, cerebrospinal fluid shunt implantation).
MEASUREMENTS AND MAIN RESULTS: Respiratory, renal, hepatic, cardiovascular, and hematologic organ system functions were evaluated both individually and in aggregate by using a modified version of the Multiple Organ Dysfunction (mMOD) score. Of 1,452 organ system functions assessed in 242 patients during their NICU stay, 714 organ system functions were intact (cerebral: 0, extracerebral: 714), 556 organ systems had mild-to-moderate dysfunctions (mMOD scoremax 1-2 for the affected organ system; cerebral: 153, extracerebral: 403), and 182 organ systems failed (mMOD scoremax 3 for the affected organ system; cerebral: 89, extracerebral: 93). Severity of extracerebral organ system dysfunctions correlated with the degree of neurologic impairment (Hunt and Hess [H&H] score) in a graded fashion. Similarly, the chance to develop systemic inflammatory response syndrome (SIRS) during the NICU stay increased with increasing admission H&H grade. The incidence of SIRS and septic shock was 29% and 10.3%, respectively. The mortality rate was 40.2% in patients with SIRS and 80% for patients suffering septic shock. Seventy-seven percent of extracerebral organ system failures (OSFs) occurred in conjunction with SIRS: 51% of respiratory OSFs, 97% of renal OSFs, 100% of hepatic OSFs, 96% of cardiovascular OSFs, and 73% of hematopoietic OSFs. Both CNS dysfunction and extracerebral organ system dysfunctions were significantly related to neurologic outcome. The probability of unfavorable neurologic outcome significantly increased with both decreasing cerebral perfusion pressure (CPP) and increasing severity of extracerebral organ dysfunction.
CONCLUSION: Aneurysmal SAH and its neurologic sequelae accounted for the principal morbidity and mortality in the current series. Development of extracerebral organ system dysfunction was associated with a higher probability of unfavorable neurologic outcome. Systemic inflammation (SIRS) and secondary organ dysfunction were the principal non-neurologic causes of death.

Entities:  

Mesh:

Year:  1999        PMID: 10199529     DOI: 10.1097/00003246-199903000-00026

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol.

Authors:  Dong H Kim; Charles L Haney; Grace Van Ginhoven
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage.

Authors:  Wouter J Schuiling; Paul J W Dennesen; Gabriël J E Rinkel
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Martin Kieninger; Daniel Unbekannt; André Schneiker; Barbara Sinner; Sylvia Bele; Christopher Prasser
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

4.  Does prone positioning increase intracranial pressure? A retrospective analysis of patients with acute brain injury and acute respiratory failure.

Authors:  Christian Roth; Andreas Ferbert; Wolfgang Deinsberger; Jens Kleffmann; Stefanie Kästner; Jana Godau; Marc Schüler; Michael Tryba; Markus Gehling
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

5.  [Inverted takotsubo cardiomyopathy due to subarachnoid haemorrhage].

Authors:  G Michels; R Pfister
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-21       Impact factor: 0.840

6.  Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Authors:  Alan K H Tam; Don Ilodigwe; Jay Mocco; Stephan Mayer; Neal Kassell; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

7.  Hemoglobin metabolism by-products are associated with an inflammatory response in patients with hemorrhagic stroke.

Authors:  Cássia Righy; Ricardo Turon; Gabriel de Freitas; André Miguel Japiassú; Hugo Caire de Castro Faria Neto; Marcelo Bozza; Marcus F Oliveira; Fernando A Bozza
Journal:  Rev Bras Ter Intensiva       Date:  2018-03-15

Review 8.  Anemia and transfusion after subarachnoid hemorrhage.

Authors:  Peter D Le Roux
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

9.  Cerebro-pulmonary interactions during the application of low levels of positive end-expiratory pressure.

Authors:  Luciana Mascia; Salvatore Grasso; Tommaso Fiore; Francesco Bruno; Maurizio Berardino; Alessandro Ducati
Journal:  Intensive Care Med       Date:  2005-01-25       Impact factor: 17.440

10.  Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage.

Authors:  Pieter M Cobelens; Ivo A C W Tiebosch; Rick M Dijkhuizen; Peter H van der Meide; René Zwartbol; Cobi J Heijnen; Jozef Kesecioglu; Walter M van den Bergh
Journal:  Crit Care       Date:  2010-08-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.